Dr. Jonathan Goldstein
Claim this profileRochester Clinical Research
Affiliated Hospitals
Rochester Clinical Research
Rochester Clinical Research /ID# 236842
Clinical Trials Jonathan Goldstein is currently running
TAK-279
for Ulcerative Colitis
The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate any problems. The participants will take capsules of either TAK-279 or placebo for up to 3 months (12 weeks). Then all the participants will receive TAK-279 for the rest of the treatment part of the study (1 year or 52 weeks). During the study, participants will visit their study clinic several times.
Recruiting
0 awards
Phase 2
1 criteria
TAK-279
for Crohn's Disease
Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy and safety of TAK-279 versus placebo in participants with moderately to severely active Crohn's disease (CD). The main aim of this study is to learn if the 3 different doses of TAK-279 reduce bowel inflammation and ulcers in the bowel compared to the placebo after 12 weeks of treatment. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate medical problems. An endoscopy will be used to check the bowel for inflammation. The participants will be treated with TAK-279 for 52 weeks (1 year). During the study, participants will visit their study clinic 15 times.
Recruiting
0 awards
Phase 2
More about Jonathan Goldstein
Clinical Trial Related
3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Jonathan Goldstein has experience with
- TAK-279
- ABX464
- TAK-062
Breakdown of trials Jonathan Goldstein has run
Colitis
Ulcerative Colitis
Celiac Disease
Crohn's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan Goldstein specialize in?
Jonathan Goldstein focuses on Colitis and Ulcerative Colitis. In particular, much of their work with Colitis has involved treating patients, or patients who are undergoing treatment.
Is Jonathan Goldstein currently recruiting for clinical trials?
Yes, Jonathan Goldstein is currently recruiting for 2 clinical trials in Rochester New York. If you're interested in participating, you should apply.
Are there any treatments that Jonathan Goldstein has studied deeply?
Yes, Jonathan Goldstein has studied treatments such as TAK-279, ABX464, TAK-062.
What is the best way to schedule an appointment with Jonathan Goldstein?
Apply for one of the trials that Jonathan Goldstein is conducting.
What is the office address of Jonathan Goldstein?
The office of Jonathan Goldstein is located at: Rochester Clinical Research, Rochester, New York 14618 United States. This is the address for their practice at the Rochester Clinical Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.